CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,800 | -31.4% | 20,000 | -17.5% | 0.00% | – |
| Q2 2023 | $27,404 | -79.4% | 24,251 | -76.8% | 0.00% | – |
| Q1 2023 | $132,716 | +137.0% | 104,501 | +135.0% | 0.00% | – |
| Q4 2021 | $56,000 | -52.5% | 44,472 | -15.6% | 0.00% | – |
| Q3 2021 | $118,000 | +29.7% | 52,700 | +17.1% | 0.00% | – |
| Q2 2021 | $91,000 | -50.5% | 45,000 | -30.6% | 0.00% | – |
| Q3 2020 | $184,000 | -46.2% | 64,800 | -30.1% | 0.00% | – |
| Q2 2020 | $342,000 | +100.0% | 92,700 | +34.1% | 0.00% | – |
| Q1 2020 | $171,000 | +338.5% | 69,137 | +587.5% | 0.00% | – |
| Q4 2019 | $39,000 | +56.0% | 10,057 | -21.2% | 0.00% | – |
| Q3 2019 | $25,000 | -74.5% | 12,768 | -42.7% | 0.00% | – |
| Q3 2018 | $98,000 | -21.6% | 22,300 | -28.8% | 0.00% | – |
| Q1 2018 | $125,000 | -64.3% | 31,300 | -32.8% | 0.00% | – |
| Q2 2017 | $350,000 | +66.7% | 46,610 | +130.6% | 0.00% | – |
| Q4 2016 | $210,000 | +101.9% | 20,213 | +101.1% | 0.00% | – |
| Q2 2016 | $104,000 | – | 10,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |